Table S2 from SPARC Expression Did Not Predict Efficacy of <i>nab</i>-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

<p>Table S2. Baseline Characteristics in the Tumor SPARC-Evaluable Population</p>